Private Equity Round in 2022
Veranex is the first truly end-to-end, global, tech-enabled, concept-through-commercialization service provider that focuses solely on medical technology: medical device, diagnostics, companion diagnostics, digital health, and drug delivery. For all your needs through the entire medical device clinical trial process, Veranex is transforming medtech innovations.
Click Therapeutics, Inc. specializes in the engineering, validation, development, and commercialization of digital therapeutic solutions aimed at addressing unmet medical needs through cognitive and neurobehavioral modification. Founded in 2012 and based in New York, the company offers innovative digital therapeutics for a range of conditions, including smoking cessation, major depressive disorder, schizophrenia, insomnia, and chronic pain. Its Digital Therapeutics™ are designed to function independently or alongside traditional biomedical treatments, utilizing the Clickometrics® adaptive data science platform to personalize user experiences and enhance engagement. Notably, Click's smoking cessation program has gained widespread access through various payers and providers, while its primary prescription program is advancing into a significant phase III clinical trial for major depressive disorder in adults.
Keystone Dental was founded in March 2006, and aspires to build a market leading, global brand recognized within the dental community for its integrity, trust and commitment to improving the standard of care for patients and their quality of life. Since then, they have rapidly grown into a diversely skilled, fast-moving team of professionals committed to providing excellent customer service and producing high-quality products and services.
TailorMed Medical Ltd. is a health technology company that specializes in financial navigation systems designed to assist patients and healthcare providers in managing medical expenses. Founded in 2017 and based in Tel Aviv, Israel, TailorMed offers a comprehensive platform that automates financial processes, identifies patients at financial risk, and connects them with tailored funding opportunities. Its key products include TailorMed Financial Navigation, which streamlines financial operations for healthcare centers; TailorMed Financial Insights, a reporting dashboard that tracks key performance indicators; and TailorMed Pharmacy, which simplifies the ordering and billing of medications based on individual treatment plans. By leveraging advanced algorithms and a robust data set, TailorMed aims to reduce patient financial toxicity and improve efficiencies throughout the treatment lifecycle.
Cynerio Israel Ltd is a cybersecurity company that focuses on protecting healthcare providers from cyber threats targeting patient data and connected medical devices. Founded in 2017 and headquartered in Tel Aviv, Israel, Cynerio offers a platform that utilizes device behavior learning and medical workflow analysis to ensure comprehensive visibility into device activities on the network. This capability allows for the detection of anomalous behavior and the mitigation of associated risks, thereby enhancing the security of sensitive healthcare information and equipment.
Memic Innovative Surgery develops and delivers robotic surgical solutions designed to enable otherwise infeasible surgical procedures. Its first offering facilitates a variety of robotic gynecological procedures via a vaginal approach, expanding the feasibility of vaginal surgery to the vast majority of cases. Its robotic technology consists of miniature and humanoid-shaped articulated arms that mimic human dexterity while surpassing human flexibility. The robotic arms are controllable via various proprietary control consoles to maintain natural control of the arms, allowing surgeons to operate precisely in tight anatomical spaces with decreased risk to nearby organs and tissue.
Memic Innovative Surgery develops and delivers robotic surgical solutions designed to enable otherwise infeasible surgical procedures. Its first offering facilitates a variety of robotic gynecological procedures via a vaginal approach, expanding the feasibility of vaginal surgery to the vast majority of cases. Its robotic technology consists of miniature and humanoid-shaped articulated arms that mimic human dexterity while surpassing human flexibility. The robotic arms are controllable via various proprietary control consoles to maintain natural control of the arms, allowing surgeons to operate precisely in tight anatomical spaces with decreased risk to nearby organs and tissue.
Private Equity Round in 2021
MedMinder Systems provides services that simplify medication management and improve medication adherence. It offers an automatic pill dispenser that reminds users when it is time to take their medication through flashes, beeps, text messages, and phone calls. It also provides the user's caregivers, family members, or pharmacists with notifications about their dosage activity, which can be monitored remotely through a patient profile's on MedMinder's website.
The company was founded in 2007 and is headquartered in Needham, Massachusetts.
Private Equity Round in 2021
MedMinder Systems provides services that simplify medication management and improve medication adherence. It offers an automatic pill dispenser that reminds users when it is time to take their medication through flashes, beeps, text messages, and phone calls. It also provides the user's caregivers, family members, or pharmacists with notifications about their dosage activity, which can be monitored remotely through a patient profile's on MedMinder's website.
The company was founded in 2007 and is headquartered in Needham, Massachusetts.
Diagnostic Robotic develops a signal-agnostic artificial intelligence system for healthcare insurers, providers, and patients. It allows to build powerful predictive analytics models that will solve a world-wide challenge, strained health budgets, and workforces.
Diagnostic Robotic was founded on 2017 and is headquartered in Tel Aviv, Israel.
Private Equity Round in 2020
NeuroPace, Inc. specializes in the design, development, manufacturing, and marketing of implantable devices aimed at treating neurological disorders through responsive stimulation. The company's flagship product, the RNS System, is specifically designed for patients with medically refractory partial epilepsy. This system includes a small implantable neurostimulator that monitors brain activity and delivers electrical pulses to targeted areas to prevent seizures. The RNS System comprises various components, such as depth leads and cortical strip leads for implantation, along with external devices like a programmer that allows healthcare professionals to communicate with the neurostimulator. Founded in 1997, NeuroPace is headquartered in Mountain View, California.
TearLab Corporation is an in-vitro diagnostic company based in Escondido, California, specializing in the development of lab-on-a-chip technologies for eye care. The company's flagship product, the TearLab Osmolarity System, is a proprietary platform designed for the diagnosis of dry eye disease by measuring tear film osmolarity. This system enables eye care practitioners to test for specific biomarkers using minimal tear samples at the point-of-care. The TearLab Osmolarity System includes a disposable microfluidic microchip, a hand-held device called the TearLab Pen, and a desktop unit, the TearLab Reader, which provides quantitative readings. Established in 1996, TearLab was formerly known as OccuLogix, Inc., and as of July 2020, it has transitioned to a private company.
BioProtect Ltd. is an international medical device startup. It is primarily engaged in to the business of developing and commercializing biodegradable balloon spacers for the protection of normal tissue during cancer radiation therapy. The company's current focus in the growing radiotherapy spacers market, where its ProSpace balloon spacer (CE marked) has shown superior efficacy and safety in protecting the rectum during radiation therapy for prostate cancer. The company's technology platform of biodegradable implantable balloons suits a wide range of applications for unmet clinical needs. BioProtect was founded in the year 2004 and headquartered in Israel, with subsidiaries in Germany and US.
Diagnostic Robotic develops a signal-agnostic artificial intelligence system for healthcare insurers, providers, and patients. It allows to build powerful predictive analytics models that will solve a world-wide challenge, strained health budgets, and workforces.
Diagnostic Robotic was founded on 2017 and is headquartered in Tel Aviv, Israel.
EndoGastric Solutions, Inc. is a medical device company focused on developing and commercializing innovative surgical technologies for the treatment of gastrointestinal diseases, particularly gastroesophageal reflux disease (GERD). The company offers a range of products, including the EsophyX technology, which facilitates transoral reconstructive surgery, and the EsophyX Z device used in the transoral incisionless fundoplication (TIF) procedure. Additionally, it provides SerosaFuse Fasteners, a non-resorbable material that matches the strength of traditional sutures. EndoGastric Solutions also supports healthcare professionals through training courses and various consultative services. Established in 2002 and headquartered in Redmond, Washington, with an office in San Mateo, California, the company has evolved from its original name, EsophyX, Inc., which it adopted in 2005.
Cynerio Israel Ltd is a cybersecurity company that focuses on protecting healthcare providers from cyber threats targeting patient data and connected medical devices. Founded in 2017 and headquartered in Tel Aviv, Israel, Cynerio offers a platform that utilizes device behavior learning and medical workflow analysis to ensure comprehensive visibility into device activities on the network. This capability allows for the detection of anomalous behavior and the mitigation of associated risks, thereby enhancing the security of sensitive healthcare information and equipment.
Strata Skin Sciences is a medical technology company that develops, commercializes, and markets products for treating dermatologic conditions, primarily in the United States and Asia. The company operates in two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its key products include the XTRAC excimer laser and VTRAC lamp systems, which are employed in treating skin disorders such as psoriasis, vitiligo, atopic dermatitis, and eczema. Additionally, Strata offers the MelaFind system, designed to assist in the identification and management of melanoma skin cancer. The company's products are distributed internationally through various distributors and directly to physicians in the domestic market. Founded in 1989, Strata Skin Sciences is headquartered in Horsham, Pennsylvania.
Cynerio Israel Ltd is a cybersecurity company that focuses on protecting healthcare providers from cyber threats targeting patient data and connected medical devices. Founded in 2017 and headquartered in Tel Aviv, Israel, Cynerio offers a platform that utilizes device behavior learning and medical workflow analysis to ensure comprehensive visibility into device activities on the network. This capability allows for the detection of anomalous behavior and the mitigation of associated risks, thereby enhancing the security of sensitive healthcare information and equipment.
Cogentix Medical products have increased treatment efficiency and lowered patient risk. Macroplastique® established the European market for bulking agents, EndoSheath® protective barrier redefined endoscopy and Urgent® PC set the standard for percutaneous tibial nerve stimulation (PTNS) as a treatment for Overactive Bladder. Cogentix Medical was formed in 2015 following a merger of Uroplasty and Vision-Sciences.
SoniVie is developing an advanced denervation solution to treat pulmonary hypertension.
Corvia Medical, Inc. is a medical device company specializing in the development of structural heart devices aimed at treating heart failure. The company's primary innovation is the InterAtrial Shunt Device (IASD), a transcatheter device designed to address diastolic heart failure (DHF), also referred to as heart failure with preserved ejection fraction (HFpEF). The IASD system works by creating a small opening between the left and right atria, which helps to lower elevated left atrial pressure, a main contributor to DHF symptoms. Founded in 2009 and based in Andover, Massachusetts, Corvia Medical was previously known as DC Devices Inc. and rebranded in June 2015. Through its innovative approach, the company aims to alleviate symptoms and enhance the quality of life for patients affected by heart failure.
Eximo Medical Ltd. develops hybrid catheter technology for tissue resection invascular and gastrointestinal endoluminal applications. The company’s technology includes CatHI, a single-use hybrid catheter that provides optical fibers that deliver short laser pulse, and a blunt mechanical knife. Its clinical applications also comprise lead extraction and peripheral artery disease. The company was founded in 2012 and is based in Modi'in-Maccabim-Re'ut, Israel. As of October 2, 2019, Eximo Medical Ltd. operates as a subsidiary of AngioDynamics, Inc.
Digma Medical is a clinical stage medical device company established in 2013, focused on innovating treatments for Type-2 Diabetes and related metabolic syndromes, including NASH. The company is developing the DiaGone™, an endoscopic and disposable device that employs advanced laser technology to treat the duodenum without the need for an implant. The Duodenal Glycemic Control™ procedure, which lasts approximately 30 minutes, allows gastroenterologists to use the DiaGone™ to enhance the body's ability to regulate glucose levels. This approach aims to offer patients the potential for long-term remission from Type-2 Diabetes and other metabolic conditions, thereby improving their overall quality of life and health outcomes. Supported by prominent venture capital firms, Digma Medical is dedicated to advancing effective therapies for diabetes management.
ECPM is a medical device company focused on designing and commercializing a platform of products and services for gastrointestinal caregivers. The Company offers a range of products and services that span single-use devices and infection control products, pathology, and imaging systems. Its products are used in colonoscopy and procedures of the upper GI tract, including esophagogastroduodenoscopy (EGD).
The company is headquartered in Alpharetta, Georgia.
Corvia Medical, Inc. is a medical device company specializing in the development of structural heart devices aimed at treating heart failure. The company's primary innovation is the InterAtrial Shunt Device (IASD), a transcatheter device designed to address diastolic heart failure (DHF), also referred to as heart failure with preserved ejection fraction (HFpEF). The IASD system works by creating a small opening between the left and right atria, which helps to lower elevated left atrial pressure, a main contributor to DHF symptoms. Founded in 2009 and based in Andover, Massachusetts, Corvia Medical was previously known as DC Devices Inc. and rebranded in June 2015. Through its innovative approach, the company aims to alleviate symptoms and enhance the quality of life for patients affected by heart failure.
Cartiheal Ltd., a medical device company, develops implants for the regeneration of cartilage and bone disorders. The company offers Agili-C, an off the shelf and cell-free implant that regenerates hyaline cartilage and its underlying subchondral bone. Its implant is used for the treatment of focal articular cartilage and osteochondral defects. The company was founded in 2009 and is based in Kfar Sava, Israel.
Digma Medical is a clinical stage medical device company established in 2013, focused on innovating treatments for Type-2 Diabetes and related metabolic syndromes, including NASH. The company is developing the DiaGone™, an endoscopic and disposable device that employs advanced laser technology to treat the duodenum without the need for an implant. The Duodenal Glycemic Control™ procedure, which lasts approximately 30 minutes, allows gastroenterologists to use the DiaGone™ to enhance the body's ability to regulate glucose levels. This approach aims to offer patients the potential for long-term remission from Type-2 Diabetes and other metabolic conditions, thereby improving their overall quality of life and health outcomes. Supported by prominent venture capital firms, Digma Medical is dedicated to advancing effective therapies for diabetes management.
ECPM is a medical device company focused on designing and commercializing a platform of products and services for gastrointestinal caregivers. The Company offers a range of products and services that span single-use devices and infection control products, pathology, and imaging systems. Its products are used in colonoscopy and procedures of the upper GI tract, including esophagogastroduodenoscopy (EGD).
The company is headquartered in Alpharetta, Georgia.
ValCare, Inc., a medical device company, designs and develops devices and accessories for minimally invasive treatment of heart valve disease. The company was founded in 2012 and is based in Irvine, California.
Cartiheal Ltd., a medical device company, develops implants for the regeneration of cartilage and bone disorders. The company offers Agili-C, an off the shelf and cell-free implant that regenerates hyaline cartilage and its underlying subchondral bone. Its implant is used for the treatment of focal articular cartilage and osteochondral defects. The company was founded in 2009 and is based in Kfar Sava, Israel.
Cartiheal Ltd., a medical device company, develops implants for the regeneration of cartilage and bone disorders. The company offers Agili-C, an off the shelf and cell-free implant that regenerates hyaline cartilage and its underlying subchondral bone. Its implant is used for the treatment of focal articular cartilage and osteochondral defects. The company was founded in 2009 and is based in Kfar Sava, Israel.
Pi-Cardia is a medical device start-up focused on developing an innovative catheter designed to treat aortic stenosis. The company’s proprietary technology utilizes a low-profile trans-femoral catheter that incorporates nitinol elements to deliver mechanical impact, creating fractures in calcified heart valves without damaging the surrounding soft tissues. This procedure, which takes only a few seconds, aims to increase the effective orifice area of the valve, providing a less invasive alternative to valve replacement. Pi-Cardia's approach seeks to offer a cost-effective and durable treatment option for patients suffering from this condition.
ECPM is a medical device company focused on designing and commercializing a platform of products and services for gastrointestinal caregivers. The Company offers a range of products and services that span single-use devices and infection control products, pathology, and imaging systems. Its products are used in colonoscopy and procedures of the upper GI tract, including esophagogastroduodenoscopy (EGD).
The company is headquartered in Alpharetta, Georgia.
Medical Compression Systems (MCS) Ltd. provides solutions for the prevention of deep vein thrombosis (DVT) and venous thromboembolism (VTE). The company’s product pipeline includes ActiveCare+S.F.T., a non-pharmaceutical mechanical solution that provides the prevention of DVT/VTE for in and out of hospital patient settings; and ActiveCare+DTx, which prevents DVT, as well as identifies proximal venous flow obstruction. Its product pipeline also comprises the ActiveCast, a device for bone fracture treatment; and the ActiveCare Vascular, a device used in the outpatient wound care market.
Cartiheal Ltd., a medical device company, develops implants for the regeneration of cartilage and bone disorders. The company offers Agili-C, an off the shelf and cell-free implant that regenerates hyaline cartilage and its underlying subchondral bone. Its implant is used for the treatment of focal articular cartilage and osteochondral defects. The company was founded in 2009 and is based in Kfar Sava, Israel.